CollPlant Biotechnologies (CLGN) Cash & Equivalents (QoQ) (2018 - 2024)
CollPlant Biotechnologies (CLGN) Cash & Equivalents (QoQ) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -22.52% |
| Sep 30, 2024 | -18.76% |
| Jun 30, 2024 | -29.07% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -7.96% |
| Sep 30, 2023 | 29.58% |
| Jun 30, 2023 | -25.11% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -8.99% |
| Sep 30, 2022 | -10.11% |
| Jun 30, 2022 | -11.60% |
| Mar 31, 2022 | 214.06% |
| Dec 31, 2021 | -49.38% |
| Sep 30, 2021 | 46.95% |
| Jun 30, 2021 | -11.23% |
| Mar 31, 2021 | 464.66% |
| Dec 31, 2020 | -32.41% |
| Sep 30, 2020 | 35.47% |
| Jun 30, 2020 | -33.47% |
| Mar 31, 2020 | 45.76% |